BridgeBio Pharma Inc (NAS:BBIO)
$ 27.94 0.18 (0.65%) Market Cap: 5.23 Bil Enterprise Value: 6.44 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

BridgeBio Pharma Inc Annual Shareholders Meeting Transcript

Jun 02, 2020 / 06:00PM GMT
Release Date Price: $29 (+0.42%)
Operator

Welcome to the 2020 Annual Meeting for BridgeBio Pharma, Inc. Our host for today's call is Neil Kumar, CEO. (Operator Instructions)

I will now turn the call over to your host. Mr. Kumar, you may begin, sir.

Neil Kumar
BridgeBio Pharma, Inc. - Co-Founder, CEO & Director

Thank you so much. Good morning, everyone. My name is Neil Kumar, Chief Executive Officer of BridgeBio Pharma, and I'll be presiding as Chairman of the meeting. The meeting is now called to order. I've asked Brian Stephenson, Chief Financial Officer and Secretary, to record the minutes of the meeting. It is a pleasure to welcome our stockholders and visitors to the annual meeting of BridgeBio Pharma. We are conducting this meeting entirely as an audio webcast. We hope that hosting the meeting virtually will allow a broader group of stockholders to participate. This meeting is being held in accordance with the corporation's bylaws and Delaware law.

In our meeting today, we will review the matters described in our notice and proxy statement, a copy of which was mailed on or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot